Evolution of Symptoms After Anterior Sacrospinofixation by Autologous Tissues
SANTAU
Prospective Study of the Evolution of Symptoms After Anterior Sacrospinofixation by Autologous Tissues
2 other identifiers
observational
66
1 country
1
Brief Summary
Prolapse is a pathology that can cause pelvic, urinary or sexual functional disorders and impaired quality of life. Although the use of vaginal mesh is a commonly practiced technique to correct prolapse, in recent years health officials have pointed to the lack of adequate safety and tolerability assessments of these implants. Currently, surgeons are therefore moving towards techniques without implants. The standard vaginal technique for the treatment of uterine prolapse is sacrospinofixation according to Richter. This technique can be performed without an implant, using autologous tissue. Functional discomfort of patients is the main problem linked to the presence of prolapse. However, no study has yet evaluated the feelings of patients following the use of this sacrospinofixation technique by autologous tissues by vaginal route, which led us to set up this study. The hypothesis is that the technique of anterior sacrospinofixation by autologous tissues improves the symptoms experienced by patients with an mid-level and / or anterior genital prolapse.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2020
CompletedFirst Posted
Study publicly available on registry
February 17, 2020
CompletedStudy Start
First participant enrolled
July 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2025
CompletedMarch 6, 2026
March 1, 2026
5.3 years
February 12, 2020
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
improvement of symptoms
percentage of patients with symptom change on the PGI-I scale (score 1, 2, or 3)
at Month 2
Study Arms (1)
anterior sacrospinofixation with autologous tissue
patients with middle and / or anterior prolapse ≥ II in the POP-Q classification and for whom an intervention by anterior sacrospinofixation by autologous tissues is planned.
Interventions
evolution of symptoms on the PGI-I scale (score 1, 2, or 3) 2 months after surgery
Eligibility Criteria
patients over 18 years old with middle and / or anterior prolapse ≥ II in the POP-Q classification and for whom an intervention by anterior sacrospinofixation by autologous tissues is planned.
You may qualify if:
- women over 18
- middle and / or anterior genital prolapse (hysterocele and / or cystocele) requiring surgical correction of stage ≥ II in the POP-Q classification
- patients wanting an intervention because of the discomfort caused by the prolapse
- intervention planned by anterior sacrospinofixation by autologous tissues
- person having expressed his non-opposition
You may not qualify if:
- prolapse of stage \< II in the POP-Q classification, or prolapse without functional impairment
- disorders involving an unacceptable risk of postoperative complications sought after questioning of the patient (blood coagulation disorders, immune system disorders, progressive diseases, etc.)
- reduced mobility of the lower limbs (not allowing positioning for surgery)
- pregnancy or any pregnancy plan for the duration of the study
- active or latent infection
- inability to understand the information given
- person deprived of liberty, under guardianship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospices Civils de Lyon
Bron, 69500, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Géry LAMBLIN, MD
Hospices Civils de Lyon
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2020
First Posted
February 17, 2020
Study Start
July 21, 2020
Primary Completion
October 28, 2025
Study Completion
October 28, 2025
Last Updated
March 6, 2026
Record last verified: 2026-03